Mettler-Toledo International Inc. manufactures and supplies precision instruments and services worldwide. The company operates in five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. It offers weighing instruments for laboratory, industrial, packaging, logistics, and food retailing applications; analytical instruments for use in life science; various related analytical instruments and provides automated chemistry solutions used in drug and chemical compound discovery and development; and end-of-line product inspection systems used in production and packaging for food processing and packaging, pharmaceutical, packaged consumer goods, and other industries. Its laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, titrators, physical value analyzers, and thermal analysis systems, as well as other analytical instruments; and LabX, a PC-based laboratory embedded software platform. The company's industrial solutions comprise industrial weighing instruments and terminals, automatic dimensional measurement and data capture solutions, vehicle scale systems, industrial software, and product inspection systems. Its retail weighing solutions consist of multiple weighing and food labeling solutions, stand-alone scales, and networked scales and software for handling fresh goods, such as meats, vegetables, fruits, and cheeses. The company serves the life science industry covering pharmaceutical and biotechnology companies, and independent research organizations; food and beverage producers; food retailers; chemical, specialty chemical, and cosmetics companies; transportation and logistics, metals, and electronics industries; and the academic community. The company markets its products through its direct sales force and indirect distribution channels. Mettler-Toledo International Inc. was founded in 1991 and is based in Columbus, Ohio.
Industry, Sector and Symbol
Stock Exchange NYSE
Industry Analytical instruments
Sub-IndustryLife Sciences Tools & Services
SectorComputer and Technology
Current SymbolNYSE:MTD
Previous Symbol
CUSIP59268810
Phone614-438-4511
Debt
Debt-to-Equity Ratio1.86
Current Ratio1.39
Quick Ratio1.00
Price-To-Earnings
Trailing P/E Ratio33.26
Forward P/E Ratio28.88
P/E Growth2.33
Sales & Book Value
Annual Sales$2.73 billion
Price / Sales5.37
Cash Flow$20.5822 per share
Price / Cash28.39
Book Value$21.40 per share
Price / Book27.31
Profitability
EPS (Most Recent Fiscal Year)$17.57
Net Income$375.97 million
Net Margins14.10%
Return on Equity93.15%
Return on Assets19.88%
Miscellaneous
Employees15,400
Outstanding Shares25,050,000
Market Cap$15.01 billion
OptionableOptionable
Mettler-Toledo International (NYSE:MTD) Frequently Asked Questions
What is Mettler-Toledo International's stock symbol?
Mettler-Toledo International trades on the New York Stock Exchange (NYSE) under the ticker symbol "MTD."
How were Mettler-Toledo International's earnings last quarter?
Mettler-Toledo International Inc. (NYSE:MTD) announced its earnings results on Thursday, November, 8th. The medical instruments supplier reported $5.12 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $4.99 by $0.13. The medical instruments supplier earned $734.85 million during the quarter, compared to analysts' expectations of $738.23 million. Mettler-Toledo International had a net margin of 14.10% and a return on equity of 93.15%. The firm's quarterly revenue was up 5.2% compared to the same quarter last year. During the same quarter in the previous year, the business posted $4.36 earnings per share. View Mettler-Toledo International's Earnings History.
When is Mettler-Toledo International's next earnings date?
What guidance has Mettler-Toledo International issued on next quarter's earnings?
Mettler-Toledo International updated its FY19 earnings guidance on Thursday, November, 8th. The company provided earnings per share guidance of $22.40-22.60 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $22.53. Mettler-Toledo International also updated its FY 2018 guidance to $20.20-20.25 EPS.
What price target have analysts set for MTD?
11 brokerages have issued twelve-month price objectives for Mettler-Toledo International's shares. Their forecasts range from $572.00 to $692.00. On average, they anticipate Mettler-Toledo International's stock price to reach $624.3333 in the next twelve months. This suggests a possible upside of 6.8% from the stock's current price. View Analyst Price Targets for Mettler-Toledo International.
What is the consensus analysts' recommendation for Mettler-Toledo International?
11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Mettler-Toledo International in the last year. There are currently 9 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Mettler-Toledo International.
Has Mettler-Toledo International been receiving favorable news coverage?
Media stories about MTD stock have been trending somewhat positive on Tuesday, according to InfoTrie Sentiment Analysis. The research group identifies negative and positive media coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Mettler-Toledo International earned a coverage optimism score of 1.9 on InfoTrie's scale. They also assigned news coverage about the medical instruments supplier a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the stock's share price in the next few days.
Who are some of Mettler-Toledo International's key competitors?
Some companies that are related to Mettler-Toledo International include Illumina (ILMN), Agilent Technologies (A), Waters (WAT), PerkinElmer (PKI), Bio-Rad Laboratories (BIO), Bio-Rad Laboratories, Inc. Class B (BIO.B), Bruker (BRKR), Coherent (COHR), Horiba (HRIBF), Pacific Biosciences of California (PACB), Accelerate Diagnostics (AXDX), Quanterix (QTRX), Fluidigm (FLDM), Eyepoint Pharmaceuticals (EYPT) and Harvard Bioscience (HBIO).
Who are Mettler-Toledo International's key executives?
Mettler-Toledo International's management team includes the folowing people:
- Mr. Olivier A. Filliol, Pres, CEO & Director (Age 51)
- Mr. William P. Donnelly, Exec. VP (Age 56)
- Mr. Marc de La Guéronnière, Head of European & North American Market Organizations (Age 54)
- Mr. Simon Kirk, Head of Product Inspection (Age 58)
- Mr. Shawn P. Vadala, Chief Financial Officer (Age 49)
Who are Mettler-Toledo International's major shareholders?
Mettler-Toledo International's stock is owned by a variety of of retail and institutional investors. Top institutional investors include FMR LLC (8.76%), BlackRock Inc. (6.64%), WCM Investment Management CA (5.62%), Baillie Gifford & Co. (2.36%), Bamco Inc. NY (2.23%) and Massachusetts Financial Services Co. MA (2.20%). Company insiders that own Mettler-Toledo International stock include Christian Magloth, Francis A Contino, Hans Ulrich Maerki, La Guerroniere Marc De, Michael A Kelly, Michael Heidingsfelder, Oliver A Filliol, Richard D Francis, Robert F Spoerry, Shawn Vadala, Simon Kirk, Thomas Caratsch, Thomas P Salice, Wah-Hui Chu, Waldemar Rauch and William P Donnelly. View Institutional Ownership Trends for Mettler-Toledo International.
Which major investors are selling Mettler-Toledo International stock?
MTD stock was sold by a variety of institutional investors in the last quarter, including MERIAN GLOBAL INVESTORS UK Ltd, Janus Henderson Group PLC, Pictet Asset Management Ltd., FMR LLC, Acadian Asset Management LLC, Skandinaviska Enskilda Banken AB publ, Select Equity Group L.P. and Glenmede Trust Co. NA. Company insiders that have sold Mettler-Toledo International company stock in the last year include La Guerroniere Marc De, Michael A Kelly, Michael Heidingsfelder, Robert F Spoerry, Shawn Vadala, Simon Kirk, Thomas Caratsch, Wah-Hui Chu, Waldemar Rauch and William P Donnelly. View Insider Buying and Selling for Mettler-Toledo International.
Which major investors are buying Mettler-Toledo International stock?
MTD stock was purchased by a variety of institutional investors in the last quarter, including WCM Investment Management CA, Credit Suisse AG, Putnam Investments LLC, Bank of New York Mellon Corp, Kornitzer Capital Management Inc. KS, Douglass Winthrop Advisors LLC, JPMorgan Chase & Co. and JPMorgan Chase & Co.. View Insider Buying and Selling for Mettler-Toledo International.
How do I buy shares of Mettler-Toledo International?
Shares of MTD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Mettler-Toledo International's stock price today?
One share of MTD stock can currently be purchased for approximately $584.33.
How big of a company is Mettler-Toledo International?
Mettler-Toledo International has a market capitalization of $15.01 billion and generates $2.73 billion in revenue each year. The medical instruments supplier earns $375.97 million in net income (profit) each year or $17.57 on an earnings per share basis. Mettler-Toledo International employs 15,400 workers across the globe.
What is Mettler-Toledo International's official website?
How can I contact Mettler-Toledo International?
Mettler-Toledo International's mailing address is 1900 POLARIS PARKWAY, COLUMBUS OH, 43240. The medical instruments supplier can be reached via phone at 614-438-4511 or via email at [email protected]
MarketBeat Community Rating for Mettler-Toledo International (NYSE MTD)
MarketBeat's community ratings are surveys of what our community members think about Mettler-Toledo International and other stocks. Vote "Outperform" if you believe MTD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MTD will underperform the S&P 500 over the long term. You may vote once every thirty days.
